SHANDONG XINHUA(00719): XU Lie resigns as non-executive director

16:50 31/03/2026

Shandong Xinhua Pharmaceutical Co., Ltd. (00719) announced that Mr. Xu Lie, a non-executive director, has resigned from the position of director of the company and member of the board development strategy committee due to reaching retirement age. The resignation will be effective from March 31, 2026, and Mr. Xu will not hold any position or duty in the company after that date.

SHANDONG XINHUA (00719) announced that Mr. Xu Lie, a non-executive director of the company, has resigned from the position of director and member of the Board Development Strategy Committee due to reaching retirement age. The resignation will take effect from March 31, 2026, after which Mr. Xu will not hold any position or duties in the company.

MICROTECH MED-B(02235) invested 641,000 Hong Kong dollars on March 31 to repurchase 88,000 shares.

Shanghai Fosun Pharmaceutical (02196): FXB0871 approved for clinical trials in locally advanced or metastatic solid tumors.

CHINA PENGFEI (03348) released its annual performance with a net profit attributable to shareholders of 101 million yuan, an increase of 50.02% year-on-year.

MICROTECH MED-B(02235) invested 641,000 Hong Kong dollars on March 31 to repurchase 88,000 shares.

Shanghai Fosun Pharmaceutical (02196): FXB0871 approved for clinical trials in locally advanced or metastatic solid tumors.

CHINA PENGFEI (03348) released its annual performance with a net profit attributable to shareholders of 101 million yuan, an increase of 50.02% year-on-year.